Take­da bud­gets $230M for plas­ma ther­a­py fa­cil­i­ty ex­pan­sion in Cal­i­for­nia

As a part of Take­da’s larg­er plan to boost pro­duc­tion of its plas­ma-de­rived ther­a­pies, the com­pa­ny is al­lo­cat­ing $230 mil­lion to ex­pand its man­u­fac­tur­ing site …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.